SG Americas Securities LLC purchased a new stake in Paragon 28, Inc. (NYSE:FNA – Free Report) in the 3rd quarter, HoldingsChannel reports. The fund purchased 19,101 shares of the company’s stock, valued at approximately $128,000.
Several other institutional investors have also recently made changes to their positions in the stock. PNC Financial Services Group Inc. bought a new stake in Paragon 28 in the 4th quarter valued at about $25,000. Nisa Investment Advisors LLC grew its stake in Paragon 28 by 46,660.0% in the second quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company’s stock valued at $32,000 after acquiring an additional 4,666 shares during the period. Levin Capital Strategies L.P. bought a new stake in shares of Paragon 28 during the second quarter valued at approximately $68,000. Price T Rowe Associates Inc. MD raised its position in shares of Paragon 28 by 16.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock worth $156,000 after purchasing an additional 1,766 shares during the period. Finally, Hsbc Holdings PLC acquired a new position in shares of Paragon 28 during the second quarter worth approximately $104,000. Institutional investors and hedge funds own 63.57% of the company’s stock.
Paragon 28 Stock Up 2.4 %
FNA stock opened at $4.90 on Friday. The stock’s 50 day moving average is $6.75 and its 200-day moving average is $7.53. Paragon 28, Inc. has a twelve month low of $4.66 and a twelve month high of $14.79. The firm has a market capitalization of $406.05 million, a PE ratio of -7.53 and a beta of 0.97. The company has a quick ratio of 1.70, a current ratio of 3.57 and a debt-to-equity ratio of 0.75.
Analysts Set New Price Targets
FNA has been the subject of several research reports. Needham & Company LLC reduced their price target on shares of Paragon 28 from $14.00 to $11.00 and set a “buy” rating for the company in a research report on Friday, August 9th. Piper Sandler reiterated an “overweight” rating and set a $12.00 price objective (down from $15.00) on shares of Paragon 28 in a report on Friday, August 9th.
Get Our Latest Analysis on FNA
Paragon 28 Profile
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
See Also
- Five stocks we like better than Paragon 28
- What is the Nasdaq? Complete Overview with History
- Texas Roadhouse Stock Steering for New Highs This Year
- Trading Stocks: RSI and Why it’s Useful
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Stock Dividend Cuts Happen Are You Ready?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Want to see what other hedge funds are holding FNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Paragon 28, Inc. (NYSE:FNA – Free Report).
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.